Panel Member	Clinical Research Support	Advisory Boards, Speakers Bureau, Expert Witness, or Consultant	Patent, Equity, or Royalty	Other	Date Completed
Jeremy S. Abramson, MD	None	None	None	None	11/13/2009
Ranjana H. Advani, MD	Eisai Inc.; Genentech, Inc.; Novartis Pharmaceuticals Corporation; Allos; Seattle Genetics; Pharmacyclics	Seattle Genetics	None	None	11/20/2009
C. Babis Andreadis, MD, MSCE	None	None	None	Genentech, Inc.	9/28/2009
John C. Byrd, MD	None	None	None	None	6/24/2008
Myron S. Czuczman, MD	Biogen Idec; Celgene Corporation; Centocor, Inc.; Cephalon, Inc.; GlaxoSmithKline; Novartis Pharmaceuticals Corporation	Abbott Laboratories; Amgen Inc.; Biogen Idec; Celgene Corporation; Cephalon, Inc.; Genentech, Inc.; GlaxoSmithKline; Millennium Pharmaceuticals, Inc.; Novartis Pharmaceuticals Corporation	None	None	9/28/2009
Luis E Fayad, MD	Eli Lilly and Company; Genentech, Inc.; GlaxoSmithKline; Wyeth Pharmaceuticals	Cephalon, Inc.; Eli Lilly and Company; Genentech, Inc.; Wyeth Pharmaceuticals	None	None	5/27/2008
Andres Forero, MD	Biogen Idec; Daiichi- Sankyo Co.; Eli Lilly and Company; Genentech, Inc.; BioCryst; Immunomedics; Seattle Genetics	None	None	None	9/28/2009
Lauren Gallagher, PhD	None	None	None	None	8/28/2009
Martha J. Glenn, MD	None	None	None	None	7/25/2008
Jon P. Gockerman, MD	None	None	None	None	7/23/2008
Leo I. Gordon, MD	CureTech Ltd.; Genentech, Inc.; Millennium Pharmaceuticals, Inc.; Pharmacyclics	CureTech Ltd.	None	CureTech Ltd.	7/21/2009
Kristina M Gregory, RN, MSN, OCN	None	None	None	None	8/21/2009
Nancy Lee Harris, MD	None	None	None	None	7/10/2009
Richard T. Hoppe, MD	None	None	None	None	7/22/2009
Steven M. Horwitz, MD	Genzyme Corporation; Medarex, Inc.; Merck & Co., Inc.; Allos; Gloucester	Eisai Inc.; Genentech, Inc.; Merck & Co., Inc.; allos; gloucester	None	None	11/13/2009
Mark S. Kaminski, MD	Cephalon, Inc.; Genzyme Corporation; GlaxoSmithKline; Novartis Pharmaceuticals Corporation	GlaxoSmithKline	GlaxoSmithKline	None	11/20/2009
Youn H. Kim, MD	Merck & Co., Inc.; Yaupon	Eisai Inc.; Merck & Co., Inc.; OVATION Pharmaceuticals, Inc.	None	None	11/21/2008
Ann S. LaCasce, MD	None	None	None	None	7/6/2009
Joan S McClure, MS	None	None	None	None	9/28/2009
Tariq I. Mughal, MD, FRCP	Celgene Corporation; Novartis Pharmaceuticals Corporation	Bristol-Myers Squibb Company; Celgene Corporation; Novartis Pharmaceuticals Corporation	None	None	10/7/2009
Auyporn Nademanee, MD	None	None	None	None	12/10/2008
Pierluigi Porcu, MD	None	Therakos, Inc.	None	None	7/13/2009
Oliver Press, MD, PhD	None	Genentech, Inc.; Sigma-Tau Pharmaceuticals, Inc.	None	None	12/23/2008
Leonard R. Prosnitz, MD	None	None	None	None	9/29/2009
Nishitha Reddy, MD					Pending
Mitchell R. Smith, MD, PhD	None	Celgene Corporation; Cephalon, Inc.; Genentech, Inc.; Millennium Pharmaceuticals, Inc.; Wyeth Pharmaceuticals	None	None	10/16/2009
Lubomir Sokol, MD, PhD	None	Eisai Inc.; Genentech, Inc.; Genzyme Corporation; Merck & Co., Inc.; Gloucester	None	None	11/10/2008
Hema Sundar, PhD	None	None	None	Cephalon, Inc.	12/15/2008
Lode J. Swinnen, MB, ChB	None	Enzon Pharmaceuticals; Genentech, Inc.	None	None	6/23/2008
Julie M. Vose, MD	Celgene Corporation; Millennium Pharmaceuticals, Inc.	Abbott Laboratories; Boehringer Ingelheim GmbH; Celgene Corporation; Genzyme Corporation; Millennium Pharmaceuticals, Inc.	None	Boehringer Ingelheim GmbH; Celgene Corporation; Millennium Pharmaceuticals, Inc.	7/1/2009
William G Wierda, MD, PhD	Abbott Laboratories; Bayer HealthCare; Genitope; Genmab; Memgen; sanofi-aventis U.S.; Sunesis Pharmaceuticals, Inc.	Celgene Corporation	None	None	6/20/2008
Joachim Yahalom, MD	None	None	None	None	11/20/2009
Andrew D. Zelenetz, MD, PhD	Abbott Laboratories; Cephalon, Inc.; GlaxoSmithKline; Allos Pharm; Glouster Pharm; Seattle Genetics	Biogen Idec; Eisai Inc.; GlaxoSmithKline; Millennium Pharmaceuticals, Inc.; Dava Oncology	None	None	6/2/2009

NCCN Website Supporters